Open AccessFighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease
Author(s) -
Loris Riccardo Lopetuso,
Antonio Gasbarrini
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz274
Subject(s) - immunogenicity , inflammatory bowel disease , medicine , immune system , disease , tumor necrosis factor alpha , immunology , inflammatory bowel diseases , crohn's disease , intensive care medicine
Primary or secondary nonresponse to anti-TNF–α due to immunogenicity or treatment-related side effects and the growing presence of innovative biological therapies targeting different cytokines and immune processes raise a clear need for predictors of efficacy for anti-TNF-α treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom